PCN86 DRUG UTILIZATION AND COST CONSIDERATIONS OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

May 1, 2008, 00:00
10.1016/S1098-3015(10)70262-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)70262-X/fulltext
Title : PCN86 DRUG UTILIZATION AND COST CONSIDERATIONS OF ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70262-X&doi=10.1016/S1098-3015(10)70262-X
First page :
Section Title :
Open access? : No
Section Order : 916
Categories :
Tags :
Regions :
ViH Article Tags :